Novartis (NVS) net assets (shareholders' equity)

Net assets · fiscal 2025
$46.13B

Novartis (NVS) had net assets of $46.13B at the end of fiscal 2025 (December 31, 2025). That is 4.7% higher than the $44.05B of fiscal 2024. Figures as of 18 Nov 2026, 20:58 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$46.13B
Change on fiscal 2024
+4.7%
Highest on record
$59.34Bfiscal 2022
Lowest on record
$44.05Bfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $59.34B in fiscal 2022 and the lowest $44.05B in fiscal 2024.

History · 4 fiscal years

Net assets by fiscal year

Novartis net assets (shareholders' equity), year by year

Novartis (NVS) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$46.13B 4.7% up
2024$44.05B 5.6% down
2023$46.67B 21.4% down
2022$59.34B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Novartis and comparable companies
CompanyNet assetsFiscal year
AbbVie ABBV-$3.27B2025
Merck & Co MRK$52.61B2025
UnitedHealth Group UNH$94.11B2025
Novartis NVS$46.13B2025
AstraZeneca AZN$48.67B2025
Thermo Fisher Scientific TMO$53.41B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis net assets (shareholders' equity): questions and answers

What are Novartis's net assets?

Novartis (NVS) had net assets of $46.13B at the end of fiscal 2025 (December 31, 2025). That is 4.7% higher than the $44.05B of fiscal 2024.

What are the highest and lowest net assets figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was $59.34B in fiscal 2022 and the lowest $44.05B in fiscal 2024.

How is Novartis's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/net-assets

Underlying data: Yahoo Finance.